Christopher Keenan Email & Phone Number
Vice President, Investor Relations and Corporate Communications @ Pliant Therapeutics
5 free lookup(s).
If you need more lookups,
subscriptions start at $34 USD/month.
Christopher Keenan Location
- California, United States
Christopher Keenan Work
- Vice President, Investor Relations and Corporate Communications @ (October 2020 - Present)
- Vice President, Investor Relations and Corporate Communications @ (April 2018 - October 2020)
- Vice President, Investor Relations and Corporate Communications, Depomed, Inc. @ (July 2015 - March 2018)
- Senior Director, Investor Relations and Corporate Communications, Peregrine Pharmaceuticals @ (January 2012 - June 2015)
- Director, Investor and Media Relations @ (October 2006 - January 2012)
- Director, Investor Relations and Corporate Communications @ Aradigm Corporation (April 2002 - September 2006)
- Director, Corporate Communcations @ (May 2000 - February 2001)
- Associate Director, Investor Relations and Corporate Communications, Isis Pharmaceuticals @ (March 1997 - April 2000)
- Senior Research Associate @ (August 1990 - March 1997)
Christopher Keenan Education
- Kenyon College
(English)
Christopher Keenan Skills
- Investor Relations
- Biotechnology
- Corporate Communications
- Crisis Management
- Corporate Branding
- Trade Shows
- Strategic Planning
- Crisis Communications
- Strategic Communications
- Media Relations
- Oncology
- Pharmaceutical Industry
- Lifesciences
- Editing
- Medical Devices
- Project Management
- Marketing Communications
- Public Relations
- Marketing
- Advertising
- Communications
- Business Development
- Microsoft Excel
- Social Media Marketing
- Management
- Research
- Nyse
- Road
- Acquisitions
- SAN
- Perception
- Science
- Roadshows
- Turnover
- Analytical Skill
- Retail
- Code Coverage
- IR
- Identity Management
- Institutional
- Presentations
- Competitive Intelligence
- Litigation
- Press Releases
- ISIS
- Leadership
- Analysts
- Analytical Instruments
- Budgets
- Securities
- Brand Management
- Muscle
- Interfaces
- Treatment
- Campaigns
- Withdrawals
- Profiles
- Restructuring
- Investors
- Officers
- Drug Discovery
- Federal Agencies
- Medical Imaging
- RNA
- Annual Report
- Exercises
- Defense
- Directors
- Launches
- Drug Delivery
- Components
- Life Sciences
- Multinational
- Product Development
- Resources
- Specialty Pharmaceutical
- Rebranding
- Follow on Offering
- Genetic Testing
- Literature
- Data Analysis
- Technology Platforms
- Corporate Events
- Consulting
- PKI
- Strategic Business
- Consumables
- Communication
- Finance
- Inhalation
- Keynote
- Surveillance
- Patent Litigation
- Pharmaceutical Sales
Christopher Keenan Summary
- Christopher Keenan, based in California, United States, is currently a Vice President, Investor Relations and Corporate Communications at Pliant Therapeutics. Christopher Keenan brings experience from previous roles at CytomX Therapeutics, Depomed, Inc., Avid Bioservices and Cytokinetics, Inc.. Christopher Keenan holds a Kenyon College. With a robust skill set that includes Investor Relations, Biotechnology, Corporate Communications, Crisis Management, Corporate Branding and more. Christopher Keenan has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Christopher Keenan?
Find contact details for 700 million professionals.
Top Pliant Therapeutics Employees
Eve-Irene Lepist
VP, Non-Clinical Development
South San Francisco, CA, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co